Growth Hormone Releasing Hormone Tesamorelin Powder Reduce Body Fat

1. Introduction
 
Tesamorelin is made with growth hormone-releasing factor (GRF).
Tesamorelin is used to reduce excess fat around the stomach that is caused by taking certain HIV medications. This condition is also called lipodystrophy (LYE-poe-DIS-troe-fee).
 
2. Quick Detail
 
Tesamorelin
Alias: TH-9507, ThGRF(1-44), Hex-hGRF, (Hexenoyl trans-3)-hGRF(1-44)-NH2
Sequence: Trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
MF: C221H366N72O67S
MW: 5135.77794
Purity: 99%
Specification: 2mg/vial
Appearance: White Lyophilized Powder
Place of Origin: China
Method of Analysis: HPLC
Storage: Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18° C. 
 
3. Product description
   
Tesamorelin is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group.
Tesamorelin (also known as Egrifta) is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy.
 
Tesamorelin (Egrifta) is indicated in HIV-infected patients specifically to reduce excess visceral fat (i.e., fat that accumulates in the abdominal cavity and around internal organs). It does not appear to have any impact on lipoatrophy (fat loss) of the face, buttock or limbs, or accumulating fat on either the breasts or back of the neck.
Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism. Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is clinical trials, that also promotes production and possible fat loss. Individuals with lipodystrophy may develop excess fat most notably around the liver, stomach, and other abdominal organs (visceral body fat).
 
4. How to Use Tesamorelin Peptide
 
This peptide is an injectable. It comes in a dried format and it’s meant to be reconstituted with sterile water before being injected. Full instructions should be included with each vial of Tesamorelin.
To reconstitute this lyophilized powder, add 2.1 milliliters of diluent and then combine both ingredients by carefully rolling the tube within your hands for half a minute. Don’t shake the mixture before you use it.
To store unused portions of this peptide, keep it in a fridge which features a temperature between 2-8 Celcius. Don’t store it past the expiration date. Also, keep it away from light and don’t let it freeze.